logo
Share SHARE
FONT-SIZE Plus   Neg

StemCells Announces Positive Interim Data From Spinal Cord Injury Trial

StemCells Inc. (STEM) announced that interim six-month data from the first patient cohort in the company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate (purified human neural stem cells) for chronic spinal cord injury continues to demonstrate a favorable safety profile, and shows considerable gains in sensory function in two of the three patients compared to pre-transplant baselines. The third patient remains stable.

The trial represents the first time that neural stem cells have been transplanted as a potential therapeutic agent for spinal cord injury.

The company stated that Patients in the study's first cohort all suffered a complete injury to the thoracic (chest-level) spinal cord. In a complete injury, there is no neurological function below the level of injury. All three patients were transplanted four to nine months after injury with a dose of 20 million cells at the site of injury. The surgery, immunosuppression and the cell transplants have been well tolerated by all the patients.

There were no abnormal clinical, electrophysiological or radiological responses to the cells, and all the patients were neurologically stable through the first six months following transplantation. Changes in sensitivity to touch, heat and electrical stimuli were observed in well-defined and consistent areas below the level of injury in two of the patients, while no changes were observed in the third patient, the company said.

Importantly, tests of perception of different sensory stimuli as well as measures of electrical impulse transmission across the site of injury correlate with the clinical examination, providing independent and objective confirmation of the changes in sensory function.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Eric Daniels, the former chief executive of Lloyds Banking Group, is suing the bank for hundreds of thousands of pounds in disputed bonuses, The Times reported. He was at the top job when the lender was bailed out with 20 billion pounds of taxpayer money during the 2008 financial crisis. Lowe's Companies, Inc. (LOW) reported second-quarter net earnings of $1.4 billion or $1.68 per share compared to $1.2 billion or $1.31 per share, a year ago. The second quarter results included a $96 million gain from the sale of the company's interest in its Australian joint venture. Excluding the gain,... Wal-Mart has applied for a U.S. patent for a blimp-style floating warehouse that could make deliveries through drones, Bloomberg reported. The world's largest retailer expects the proposed floating warehouse could help it lower the costs of fulfilling online orders, especially the expensive last-mile deliveries..
comments powered by Disqus
Follow RTT